The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Spikevax bivalent Original/Omicron BA.4-5
Australian Public Assessment Report
Device/Product Name
Spikevax bivalent Original/Omicron BA.4-5
Active ingredients
Elasomeran and davesomeran
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-04824-1-2
Submission Type
New biological entity
Decision
Approved for provisional registration